Aquestive Therapeutics Inc (AQST)

Total Costs & Expenses

$106.83M

TTM · Period ending: · USD

AQST logo

AQST Total Costs & Expenses

Latest reported$106.83M
AQST TTM Total Costs & Expenses ($67.03M → $106.83M)
High-resolution chart · PNG

AQST total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aquestive Therapeutics Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
106,832,000
106,161,000
115,596,000
99,188,000
96,734,000
95,407,000
88,332,000
80,003,000
73,550,000
70,956,000
65,685,000
69,963,000
74,900,000
83,477,000
89,746,000
91,098,000
92,037,000
87,872,000
85,511,000
85,559,000
86,345,000
85,763,000
88,742,000
92,270,000
93,649,000
102,186,000
105,277,000
108,127,000
107,178,000
123,975,000
116,364,000
106,642,000
100,896,000
69,483,000
67,032,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.